Clinical Trials for Hepatocellular Carcinoma

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

NCT ID: NCT05621499

This clinical trial is investigating a new treatment approach for patients with a type of liver cancer called hepatocellular carcinoma (HCC) that has a high risk of coming back after surgery. Resea...

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

NCT ID: NCT05257694

This clinical trial is focused on using advanced technology called deep learning to analyze images from a special type of ultrasound (contrast-enhanced ultrasound) to help predict how well patients...

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

NCT ID: NCT05573282

This clinical trial is studying the effects of a new treatment approach for patients with advanced liver cancer, specifically hepatocellular carcinoma (HCC). The researchers want to find out if com...

Lenvatinib Therapy in HCC Patients After LDLT

NCT ID: NCT05572528

This clinical trial is studying the use of a medication called lenvatinib in patients with liver cancer (hepatocellular carcinoma or HCC) who have undergone liver transplantation (living donor live...

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

NCT ID: NCT05171335

Prospective Cohort for Early Detection of Liver Cancer

NCT ID: NCT05541601

This clinical trial, called the Pearl cohort, is designed to help find liver cancer (specifically hepatocellular carcinoma, or HCC) earlier in people who have liver cirrhosis. The researchers want ...

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

NCT ID: NCT03482102

This clinical trial is exploring a new treatment approach for patients with hepatocellular carcinoma (a type of liver cancer) and biliary tract cancer, which are both serious conditions. The study ...

The Detection of Small Early Liver Cancer With Natural History Follow up

NCT ID: NCT05534906

The SELINA study is a clinical trial designed to improve the early detection of small liver cancer, specifically hepatocellular carcinoma (HCC). Researchers will recruit 250 participants: 200 patie...

Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates

NCT ID: NCT05276037

This clinical trial is studying the use of a specific type of imaging test called 18FDG PET/CT to help identify patients with hepatocellular carcinoma (HCC) who may be eligible for liver transplant...

Antiviral Therapy for Patients With Liver Cancer After Surgery

NCT ID: NCT05466565

This clinical trial is studying the effects of a combination treatment involving peginterferon α-2b (called pegabin) and other antiviral medications on patients who have undergone surgery for liver...

Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC

NCT ID: NCT05002452

This clinical trial is studying how certain factors that can be easily measured before surgery might help predict how well patients with advanced liver cancer (specifically, hepatocellular carcinom...

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA

NCT ID: NCT05375370

The REMNANT study is looking at a new way to help doctors understand if liver cancer (also known as hepatocellular carcinoma or HCC) might come back after treatment. Researchers want to see if they...

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

NCT ID: NCT05323201

This clinical trial is studying a new treatment for advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC). The treatment involves using specially modified immune cells, k...

Deep Liver Phenotyping and Immunology Study

NCT ID: NCT04946773

The Deep Liver Phenotyping and Immunology Study is looking into two types of liver cancer: hepatocellular carcinoma (HCC) and cholangiocarcinoma. These cancers are often found late, making them har...

PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC

NCT ID: NCT04792801

This clinical trial is studying how a special type of scan called a PET CT, which uses two different substances (FDG and Choline), can help doctors decide if patients with liver cancer, known as he...

Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation

NCT ID: NCT04595864

This clinical trial is studying a treatment called neo-adjuvant Transarterial Chemoinfusion (TAI) for patients with a type of liver cancer known as hepatocellular carcinoma (HCC). The goal is to se...

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

NCT ID: NCT05095714

The FAST-IRM clinical trial is studying a new way to help detect liver cancer, specifically hepatocellular carcinoma (HCC), in patients who are at high risk. This group includes individuals with ci...

HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

NCT ID: NCT04455932

This clinical trial is studying the best way to monitor patients at risk for liver cancer, specifically those with cirrhosis who have had difficulty getting clear images from ultrasound tests. Curr...

The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)

NCT ID: NCT04517227

The TAD trial is a study that aims to evaluate the safety and effectiveness of a new treatment approach for patients with intermediate-stage liver cancer, known as hepatocellular carcinoma (HCC). T...

Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)

NCT ID: NCT04777942

The NeoconceptA trial is studying a new treatment approach for patients with a type of liver cancer called hepatocellular carcinoma (HCC), specifically those classified as BCLC A stage with a high ...